The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: Conventional, Doppler, and tissue Doppler echocardiographic parameters

Artificial Organs

Volumn 29, Issue 12, 2005, Pages 965-972

  Kirkpantur, Alper ^a   Kahraman, Serkan ^a   Yilmaz, Rahmý ^a   Arici, Mustafa ^a   Altun, Bulent ^a   Erdem, Yunus ^a   Yasavul, Unal ^a   Turgan, Cetin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cardiac dysfunction; Doppler echocardiography; Hemodialysis; Hypertension; Recombinant human erythropoietin; Tissue Doppler imaging

Indexed keywords

BLOOD PRESSURE; BLOOD VESSELS; CARDIOLOGY; CARDIOVASCULAR SURGERY; DISEASE CONTROL; DISEASES; ECHOCARDIOGRAPHY; HEART; HEMODIALYZERS; HEMODYNAMICS; MAINTENANCE; TISSUE;

% REDUCTIONS; DOPPLER ECHOCARDIOGRAPHY; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN ERYTHROPOIETIN; HYPERTENSION; LATERAL WALLS; LEFT VENTRICULAR; RECOMBINANT HUMAN ERYTHROPOIETIN; TISSUE DOPPLER IMAGING;

DIALYSIS;

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AMBULATORY MONITORING; ANEMIA; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIALYSIS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; RECORDER; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; SYSTOLE;

ANEMIA; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING, AMBULATORY; DIASTOLE; ECHOCARDIOGRAPHY; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEART SEPTUM; HEMOGLOBINS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; STROKE VOLUME; SYSTOLE;

EID: 33644876271     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2005.00166.x     Document Type: Article

References (47)

1. Raine AEG Magreiter R Brunner FP, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transpl 1992; 7 ( Suppl. 2 7 35.
2. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis. An NIH Consensus Conference Statement. Ann Intern Med 1994 121 : 62 70.
3. Kjellstrand CM Hylander B Collins AC. Mortality on dialysis. On the influence of early start, patients' characteristics, and transplantation and acceptance rates. Am J Kidney Dis 1990 15 : 483 90.
4. Silberberg JS Rahal DP Patton R Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end stage renal disease. Am J Cardiol 1989 64 : 222 4.
5. Eckardt K-U. Cardiovascular consequences of renal anemia and erythropoietin therapy. Nephrol Dial Transpl 1999 14 : 1317 23.
6. Ritz E Schwenger V Zeier M Rychlik I. Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? Nephrol Dial Transpl 2001 16 : 1550 4.
7. Schunkert H Hense HW. A heart price to pay for anemia. Nephrol Dial Transpl 2001 16 : 445 8.
8. Smiseth OA. Assessment of ventricular diastolic function. Can J Cardiol 2001 17 : 1167 76.
9. Vasan RS Levy D. Defining diastolic heart failure. A call for standardized diagnostic criteria. Circulation 2000 101 : 2118 21.
10. Yu CM Lin H Yang H, et al. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002 105 : 1195 201.
11. Raj DS D'Mello S Somiah S Sheeba SD Mani K. Left ventricular morphology in chronic renal failure by echocardiography. Renal Failure 1997 19 : 799 806.
12. Kang SM Ha JW Rim SJ Chung N. Index of myocardial performance using Döppler-derived parameters in the evaluation of left ventricular function in patients with essential hypertension. Yonsei Med J 1998 39 : 446 52.
13. Huting J. Diastolic left ventricular function after renal transplantation in patients with normal and hypertrophied myocardium. Clin Cardiol 1992 15 : 845 50.
14. Strozecki P Adamowicz A Nartowicz E Odrowaz-Sypniewska G Wlodarczyk Z Manitius J. Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Renal Failure 2001 23 : 115 26.
15. Yu CM Wang Q Lau CP, et al. Reversible impairment of left and right ventricular systolic and diastolic function during short-lasting atrial fibrillation in patients with an implantable atrial defibrillator: a tissue doppler imaging study. Pacing Clin Electrophysiol 2001 24 : 979 88.
16. Daugirdas JT. Second generation logarithmic estimates of single pool variable Volume Kt/V: an analysis of error. J Am Soc Nephrol 1993 4 : 1205 13.
17. Sahn DJ De Maria A Kisslo J Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 1978 58 : 1072 83.
18. Reichek N Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981 65 : 99 108.
19. Bland JM Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 10.
20. Abraham PA Macres MG. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991 2 : 927 36.
21. Lebel M Kingma I Grose JH Langlois S. Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients. J Am Soc Nephrol 1998 9 : 97 104.
22. Van de Borne P Tielemans C Vanherweghem J-L Degaute J-P. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure and heart rate in chronic haemodialysis patients. Nephrol Dial Transpl 1992 7 : 45 9.
23. Imai Y Sekino H Fujikura Y, et al. Pressor effect of recombinant human erythropoietin: results of ambulatory blood pressure monitoring and home blood pressure measurements. Clin Exp Hypertens 1995 17 : 485 506.
24. Vaziri ND. Vascular effects of erythropoietin and anemia correction. Semin Nephrol 2000 20 : 356 63.
25. Bode-Boger SM Boger RH Kuhn M Radermacher J Frolich JC. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids. Kidney Int 1996 50 : 1255 61.
26. Nielsen FS Rossing P Bang LE, et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995 44 : 783 9.
27. Van Ittersum FJ Spek JJ Praet IJ, et al. Ambulatory blood pressures and autonomic nervous function in normoalbuminuric type 1 diabetic patients. Nephrol Dial Transplant 1998 13 : 326 32.
28. Mulec H Blohme G Kullenberg K Nyberg G Bjorck S. Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 1995 38 : 216 20.
29. Okada H Inoue T Takahira S Sugahara S Nakamato H Suzuki H. Daytime hypertension, sleep apnoea and metabolic alkalosis in a haemodialysis patient - the result of sodium bicarbonate abuse. Nephrol Dial Transpl 1999 14 : 452 4.
30. Amar J Vernier I Rossignol E Lenfant V Conte JJ Chamontin B. Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis. Kidney Int 1997 51 : 1863 6.
31. Conor J O'Shea JC Murphy MB. Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping? Am J Hypertens 2000 13 : 601 6.
32. Tozawa M Iseki K Yoshi S Fukiyama K. Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transpl 1999 14 : 1976 81.
33. Covic A Goldsmith DJ Covic M. Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis 2000 35 : 617 23.
34. Foley RN Parfrey PS Harnett JD, et al. The impact of anemia cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis 1996 28 : 53 61.
35. Renal Data System. USRDS 1997 Annual Data Report. Bethesda, MD : National Institutes of Diabetes and Digestive and Kidney Diseases, 1997: D1 51.
36. Radermacher J Koch KM. Treatment of renal anemia by erythropoietin substitution - the effects on the cardiovascular system. Clin Nephrol 1995 44 ( Suppl. 1 S56 60.
37. Facchin L Vescovo G Levedianos G, et al. Left ventricular morphology and diastolic function in uremia: echocardiographic evidence of a specific cardiomyopathy. Brit Heart J 1995 74 : 174 9.
38. London GM Pannier B Guerin AP Marchais SJ Safar ME Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994 90 : 2786 96.
39. Amann K Ritz E Wiest G Klaus G Mall G. The role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994 4 : 1814 9.
40. Vlahakos DV Hahalis G Vassilakos P Marathias KP Geroulanos S. Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients. J Am Soc Nephrol 1997 8 : 1764 70.
41. Demuth K Blacher J Guerin AP, et al. Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transpl 1998 13 : 375 83.
42. Bernardi D Bernini L Cini G Ghione S Bonechi I. Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Am Heart J 1985 109 : 539 45.
43. Lorell BH Carabello BA. Left ventricular hypertrophy: Pathogenesis, detection and prognosis. Circulation 2000 102 : 470 9.
44. Gupta S Dev V Kumar MV Dash SC. Left ventricular diastolic function in end stage renal disease and the impact of hemodialysis. Am J Cardiol 1993 71 : 1427 30.
45. European Study Group On Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998 19 : 990 1003.
46. Bauer F Jamal F Douillet R, et al. [Acute changes in load: effects of myocardial velocities measured by doppler tissue imaging]. Arch Mal Coeur Vaiss 2001 94 : 1155 60.
47. Dincer I Kumbasar D Nergisoglu G, et al. Assessment of left ventricular diastolic function with Doppler tissue imaging: effects of preload and place of measurements. Int J Cardiovasc Imaging 2002 18 : 155 60.